Who Paid My Doc
Priya Pillutla
Adult Congenital Heart Disease Los Angeles, CA Medical Doctor
NPI 1255453171 CMS profile 56651
100 Medical Plz, Ste. 630, Los Angeles, CA 90095
General payments
$3,974
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$116,067
Through program year 2025, Priya Pillutla of Los Angeles, CA is reported in the CMS Open Payments database as having received $3,974 across 153 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $116,067 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $577 | 9 | |
| 2024 | General | $796 | 40 | |
| 2023 | General | $969 | 33 | |
| 2022 | General | $757 | 30 | |
| 2021 | General | $437 | 18 | |
| 2020 | General | $138 | 8 | |
| 2019 | General | $300 | 15 |
Beside peers
- Priya Pillutla
- Adult Congenital Heart Disease median
- Middle half of Adult Congenital Heart Disease
- National median
In program year 2025, general payments to Priya Pillutla were reported at $577. Among 56 Adult Congenital Heart Disease profiles paid that year, the median was $272 and the middle half received between $51 and $642.
Show as a table
| Year | Priya Pillutla | Adult Congenital Heart Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $300 | $202 | $71–$498 | $163 |
| 2020 | $138 | $127 | $28–$236 | $114 |
| 2021 | $437 | $138 | $34–$310 | $132 |
| 2022 | $757 | $275 | $125–$1,572 | $149 |
| 2023 | $969 | $215 | $58–$1,454 | $160 |
| 2024 | $796 | $273 | $84–$801 | $164 |
| 2025 | $577 | $272 | $51–$642 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
153 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Adult Congenital Heart Disease in California
Taylor Holve
Adult Congenital Heart Disease · Santa Barbara, CA
Angela Li
Adult Congenital Heart Disease · Orange, CA
Ahmed Kheiwa
Adult Congenital Heart Disease · Loma Linda, CA
Prashanth Venkatesh
Adult Congenital Heart Disease · Los Angeles, CA
Ramesh Bansal
Adult Congenital Heart Disease · Loma Linda, CA
Padmini Varadarajan
Adult Congenital Heart Disease · Redlands, CA
Related records
Adult Congenital Heart Disease in California
Practitioners in the same specialty and state, ranked by reported value.
All Adult Congenital Heart Disease
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.